(Q37892524)

24 August 2017

title

Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: efficacy and tolerability (English)

1 reference

familial hypercholesterolemia

24 August 2017

0 references

1 reference

Valerie Carreau

1

1 reference

24 August 2017

Jean-Philippe Girardet

series ordinal

2

1 reference

24 August 2017

Eric Bruckert

series ordinal

3

1 reference

24 August 2017

publication date

1 August 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

13

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

267-275

1 reference

Familial hypercholesterolemia in children

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Early statin therapy restores endothelial function in children with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Lipid screening and cardiovascular health in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

What are the health effects of fat?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Statin treatment in children with familial hypercholesterolemia: the younger, the better

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Making trials matter: pragmatic and explanatory trials and the problem of applicability

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

The gap between clinical trials and clinical practice: the use of pragmatic clinical trials to inform regulatory decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Efficacy and safety of pravastatin in children and adolescents with heterozygous familial hypercholesterolemia: a prospective clinical follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Autosomal dominant type IIa hypercholesterolemia: evaluation of the respective contributions of LDLR and APOB gene defects as well as a third major group of defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

The myotoxicity of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591650-000000000-00000

Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults.

21 January 2018

1 reference

12 December 2020

Arterial mechanical changes in children with familial hypercholesterolemia

1 reference

12 December 2020

[Recommendations for hypercholesterolemic children]

1 reference

12 December 2020

Trans fatty acids and plasma lipoproteins.

1 reference

12 December 2020

Molecular spectrum of autosomal dominant hypercholesterolemia in France

1 reference

12 December 2020

National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents

1 reference

12 December 2020

Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia

1 reference

12 December 2020

Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. The Dietary Intervention Study in Children (DISC). The Writing Group for the DISC Collaborative Research Group

1 reference

12 December 2020

Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group

1 reference

12 December 2020

10.2165/11591650-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

24 August 2017

1027821728

0 references

Fatcat ID

release_mjubnimwfvdddea6ax6nm7xprq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mjubnimwfvdddea6ax6nm7xprq

24 November 2022

mapped directly with Wikidata item

1 reference